LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.50 | 21.74 | 1008 | 5425 | 0.1858 | 0.6190 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.50 | 21.74 | 1021 | 5425 | 0.1882 | 0.6216 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.50 | 21.74 | 1116 | 5425 | 0.2057 | 0.6398 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 53.50 | 21.74 | 1131 | 5425 | 0.2085 | 0.6425 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.48 | 21.74 | 1009 | 5768 | 0.1749 | 0.6106 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.48 | 21.74 | 1022 | 5768 | 0.1772 | 0.6132 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.48 | 21.74 | 1118 | 5768 | 0.1938 | 0.6313 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 55.48 | 21.74 | 1132 | 5768 | 0.1962 | 0.6338 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.45 | 21.74 | 1010 | 6023 | 0.1677 | 0.6049 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.45 | 21.74 | 1021 | 6023 | 0.1695 | 0.6071 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.45 | 21.74 | 1119 | 6023 | 0.1858 | 0.6253 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 57.45 | 21.74 | 1137 | 6023 | 0.1888 | 0.6285 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 59.42 | 21.74 | 1013 | 6125 | 0.1654 | 0.6033 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 59.42 | 21.74 | 1027 | 6125 | 0.1677 | 0.6060 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 59.42 | 21.74 | 1122 | 6125 | 0.1832 | 0.6235 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 59.42 | 21.74 | 1134 | 6125 | 0.1851 | 0.6256 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.39 | 21.74 | 1018 | 6112 | 0.1665 | 0.6045 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.39 | 21.74 | 1035 | 6112 | 0.1693 | 0.6078 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.39 | 21.74 | 1129 | 6112 | 0.1847 | 0.6250 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 62.39 | 21.74 | 1141 | 6112 | 0.1867 | 0.6272 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.36 | 21.74 | 1020 | 6191 | 0.1648 | 0.6032 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.36 | 21.74 | 1035 | 6191 | 0.1672 | 0.6061 | MN20160310_N01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.36 | 21.74 | 1127 | 6191 | 0.1820 | 0.6229 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 64.36 | 21.74 | 1143 | 6191 | 0.1846 | 0.6257 | MN20160310_N01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 66.33 | 21.74 | 1028 | 6235 | 0.1649 | 0.6038 | MN20160310_N01 | D06 |